{"id":76836,"date":"2026-11-05T04:15:04","date_gmt":"2026-11-05T04:15:04","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76836"},"modified":"2026-11-05T04:39:57","modified_gmt":"2026-11-05T04:39:57","slug":"american-analyst-updates-nov-4th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/","title":{"rendered":"American Analyst Updates: Nov 4th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

Wall Street analyst outlookt was mixed today, but leaned cautious, with downgrades outnumbering upgrades across several major sectors. Technology showed diverging trends, as analysts expressed increased optimism toward AI infrastructure, semiconductors, and cybersecurity, while Adobe and Apple faced rating downgrades amid valuation and growth concerns. AMD continued to attract favourable analyst coverage, although price target revisions were mixed. Financial services, automotive, consumer discretionary, and cryptocurrency-related stocks experienced increased downward revisions, reflecting concerns over profitability, demand, and near-term earnings expectations. Healthcare and industrial companies received selective upgrades, while new coverage highlighted opportunities in defence, cybersecurity, and biotechnology.<\/p>\n

Updates (653)<\/strong><\/h3>\n

3M (MMM)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $191.00 to $210.00 while maintaining an Overweight rating.<\/p>\n

3M (MMM)<\/strong> \u2014 UBS Group set a price target of $230.00.<\/p>\n

Aardvark Therapeutics (AARD)<\/strong> \u2014 Raymond James Financial downgraded the stock from Strong-Buy to Market Perform.<\/p>\n

AbbVie (ABBV)<\/strong> \u2014 BMO Capital Markets set a price target of $315.00.<\/p>\n

AdaptHealth (AHCO)<\/strong> \u2014 UBS Group lowered its price target for the stock from $10.00 to $9.00 while maintaining a Buy rating.<\/p>\n

Addus HomeCare (ADUS)<\/strong> \u2014 Barclays raised its price target for the stock from $96.00 to $101.00 while maintaining an Underweight rating.<\/p>\n

Adobe (ADBE)<\/strong> \u2014 Citigroup downgraded the stock from Neutral to Sell, adjusting its price target from $250.00 to $207.00.<\/p>\n

ADT (ADT)<\/strong> \u2014 Barclays upgraded the stock from Underweight to Equal Weight, with a price target of $10.00.<\/p>\n

ADTRAN (ADTN)<\/strong> \u2014 B. Riley Financial reiterated its Buy rating, and revised its price target from $21.00 to $14.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Bank of America lowered its price target for the stock from $720.00 to $650.00 while maintaining a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating, with a price target of $700.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 DA Davidson raised its price target for the stock from $550.00 to $600.00 while maintaining a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $550.00 to $575.00 while maintaining a Neutral rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 KeyCorp reiterated its Overweight rating, with a price target of $725.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Melius Research set a price target of $650.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Mizuho lowered its price target for the stock from $705.00 to $610.00 while maintaining an Outperform rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Piper Sandler raised its price target for the stock from $600.00 to $650.00 while maintaining an Overweight rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating, with a price target of $649.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $700.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Royal Bank Of Canada reiterated its Sector Perform rating, with a price target of $540.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Royal Bank Of Canada set a price target of $675.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Stifel Nicolaus raised its price target for the stock from $700.00 to $725.00 while maintaining a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating, with a price target of $675.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Truist Financial raised its price target for the stock from $594.00 to $605.00 while maintaining a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 UBS Group lowered its price target for the stock from $730.00 to $700.00 while maintaining a Buy rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Unknown brokerage reiterated its Positive rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Wedbush reiterated its Outperform rating, with a price target of $600.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $700.00 to $650.00 while maintaining an Overweight rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 William Blair reiterated its Market Perform rating.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Wolfe Research reiterated its Outperform rating, with a price target of $650.00.<\/p>\n

AG Mortgage Investment Trust (MITT)<\/strong> \u2014 JonesTrading lowered its price target for the stock from $8.00 to $7.00 while maintaining a Buy rating.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $99.00 to $113.00 while maintaining an Underweight rating.<\/p>\n

Alight (ALIT)<\/strong> \u2014 Needham & Company LLC reiterated its Hold rating.<\/p>\n

Alkermes (ALKS)<\/strong> \u2014 HC Wainwright raised its price target for the stock from $43.00 to $50.00 while maintaining a Neutral rating.<\/p>\n

Alkermes (ALKS)<\/strong> \u2014 Robert W. Baird set a price target of $34.00 to $36.00 with a Buy rating.<\/p>\n

Alkermes (ALKS)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $56.00 to $57.00 while maintaining an Outperform rating.<\/p>\n

Alkermes (ALKS)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $65.00 to $68.00 while maintaining an Overweight rating.<\/p>\n

Allison Transmission (ALSN)<\/strong> \u2014 Citigroup raised its price target for the stock from $135.00 to $140.00 while maintaining a Buy rating.<\/p>\n

Allison Transmission (ALSN)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $132.00 to $139.00 while maintaining an Equal Weight rating.<\/p>\n

Alphatec (ATEC)<\/strong> \u2014 UBS Group downgraded the stock from Buy to Neutral, adjusting its price target from $15.00 to $8.50.<\/p>\n

Amdocs (DOX)<\/strong> \u2014 Oppenheimer downgraded the stock from Outperform to Market Perform.<\/p>\n

Amdocs (DOX)<\/strong> \u2014 Stifel Nicolaus lowered its price target for the stock from $71.00 to $46.00 while maintaining a Buy rating.<\/p>\n

American International Group (AIG)<\/strong> \u2014 Bank of America reiterated its Neutral rating.<\/p>\n

American Well (AMWL)<\/strong> \u2014 Stifel Nicolaus raised its price target for the stock from $11.00 to $12.00 while maintaining a Hold rating.<\/p>\n

American Well (AMWL)<\/strong> \u2014 TD Cowen raised its price target for the stock from $12.00 to $13.00 while maintaining a Hold rating.<\/p>\n

American Well (AMWL)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $16.00 to $18.00 while maintaining an Overweight rating.<\/p>\n

AMETEK (AME)<\/strong> \u2014 Citigroup raised its price target for the stock from $263.00 to $270.00 while maintaining a Neutral rating.<\/p>\n

AMETEK (AME)<\/strong> \u2014 Mizuho lowered its price target for the stock from $285.00 to $275.00 while maintaining an Outperform rating.<\/p>\n

AMETEK (AME)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $291.00 to $308.00 while maintaining an Outperform rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $384.00 to $440.00 while maintaining a Hold rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $440.00 to $465.00 while maintaining a Neutral rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Citigroup raised its price target for the stock from $405.00 to $465.00 while maintaining a Neutral rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $350.00 to $425.00 while maintaining a Neutral rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $359.00 to $410.00 while maintaining an Equal Weight rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $430.00 to $470.00 while maintaining an Outperform rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating, with a price target of $400.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Scotiabank raised its price target for the stock from $500.00 to $530.00 while maintaining a Sector Outperform rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 TD Cowen raised its price target for the stock from $452.00 to $531.00 while maintaining a Buy rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 The Goldman Sachs Group raised its price target for the stock from $481.00 to $536.00 while maintaining a Buy rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Truist Financial raised its price target for the stock from $380.00 to $398.00 while maintaining a Hold rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 UBS Group raised its price target for the stock from $470.00 to $530.00 while maintaining a Buy rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $430.00 to $460.00 while maintaining an Equal Weight rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 William Blair reiterated its Outperform rating.<\/p>\n

Amneal Pharmaceuticals (AMRX)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $24.00 to $25.00 while maintaining an Overweight rating.<\/p>\n

Amneal Pharmaceuticals (AMRX)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating, with a price target of $21.00.<\/p>\n

Angel Oak Mortgage REIT (AOMR)<\/strong> \u2014 B. Riley Financial lowered its price target for the stock from $13.00 to $10.00 while maintaining a Buy rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Barclays lowered its price target for the stock from $157.00 to $156.00 while maintaining an Overweight rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $153.00 to $157.00 while maintaining an Overweight rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Keefe, Bruyette & Woods lowered its price target for the stock from $135.00 to $130.00 while maintaining a Market Perform rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $150.00 to $149.00 while maintaining an Overweight rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating, with a price target of $145.00.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $146.00 to $138.00 while maintaining a Sector Perform rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 TD Cowen lowered its price target for the stock from $154.00 to $136.00 while maintaining a Buy rating.<\/p>\n

Apple (AAPL)<\/strong> \u2014 DZ Bank downgraded the stock from Hold to Sell, with a price target of $300.00.<\/p>\n

Apple (AAPL)<\/strong> \u2014 The Goldman Sachs Group set a price target of $380.00.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 Barclays lowered its price target for the stock from $60.00 to $53.00 while maintaining an Overweight rating.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 BNP Paribas Exane reiterated its Outperform rating, and revised its price target from $63.00 to $59.00.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $55.00 to $45.00 while maintaining an Equal Weight rating.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $77.00 to $64.00 while maintaining an Outperform rating.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 TD Cowen lowered its price target for the stock from $77.00 to $72.00 while maintaining a Buy rating.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 The Goldman Sachs Group lowered its price target for the stock from $61.00 to $54.00 while maintaining a Buy rating.<\/p>\n

ArcBest (ARCB)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

ArcBest (ARCB)<\/strong> \u2014 TD Cowen reiterated its Hold rating.<\/p>\n

Archer Daniels Midland (ADM)<\/strong> \u2014 JPMorgan Chase & Co. upgraded the stock from Underweight to Neutral, with a price target of $75.00.<\/p>\n

Archer Daniels Midland (ADM)<\/strong> \u2014 Stephens lowered its price target for the stock from $85.00 to $75.00 while maintaining an Equal Weight rating.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Barclays lowered its price target for the stock from $289.00 to $236.00 while maintaining an Overweight rating.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $250.00 to $270.00 while maintaining an Overweight rating.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Melius Research set a price target of $305.00.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating, and revised its price target from $220.00 to $230.00.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, with a price target of $260.00.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Piper Sandler raised its price target for the stock from $240.00 to $261.00 while maintaining an Overweight rating.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $280.00.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Truist Financial raised its price target for the stock from $234.00 to $240.00 while maintaining a Buy rating.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 UBS Group reiterated its Buy rating, and revised its price target from $259.00 to $291.00.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Wells Fargo & Company reiterated its Overweight rating, and revised its price target from $255.00 to $245.00.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $382.00 to $389.00 while maintaining an Overweight rating.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $425.00 to $300.00 while maintaining a Buy rating.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 Northland Securities upgraded the stock from Market Perform to Outperform, with a price target of $315.00.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $500.00 to $400.00 while maintaining an Outperform rating.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 Susquehanna lowered its price target for the stock from $310.00 to $258.00 while maintaining a Neutral rating.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 TD Cowen lowered its price target for the stock from $300.00 to $225.00 while maintaining a Hold rating.<\/p>\n

Astera Labs (ALAB)<\/strong> \u2014 UBS Group lowered its price target for the stock from $300.00 to $290.00 while maintaining a Neutral rating.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Piper Sandler lowered its price target for the stock from $15.00 to $13.00 while maintaining a Neutral rating.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $16.00 to $13.00 while maintaining a Sector Perform rating.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Scotiabank raised its price target for the stock from $17.00 to $18.00 while maintaining a Sector Outperform rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 BTIG Research raised its price target for the stock from $63.00 to $70.00 while maintaining a Buy rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $55.00 to $67.00 while maintaining a Buy rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $36.00 to $62.00 while maintaining a Neutral rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $64.00 to $70.00 while maintaining a Buy rating.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating, and revised its price target from $60.00 to $70.00.<\/p>\n

AutoNation (AN)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $185.00.<\/p>\n

Avis Budget Group (CAR)<\/strong> \u2014 Susquehanna reiterated its Neutral rating, with a price target of $125.00.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong> \u2014 Mizuho lowered its price target for the stock from $284.00 to $272.00 while maintaining an Outperform rating.<\/p>\n

Ball (BALL)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $65.00.<\/p>\n

Ball (BALL)<\/strong> \u2014 Mizuho raised its price target for the stock from $72.00 to $75.00 while maintaining an Outperform rating.<\/p>\n

Ball (BALL)<\/strong> \u2014 Truist Financial reiterated its Buy rating, and revised its price target from $78.00 to $76.00.<\/p>\n

Ball (BALL)<\/strong> \u2014 UBS Group raised its price target for the stock from $63.00 to $68.00 while maintaining a Neutral rating.<\/p>\n

Beam Therapeutics (BEAM)<\/strong> \u2014 Canaccord Genuity Group lowered its price target for the stock from $79.00 to $78.00 while maintaining a Buy rating.<\/p>\n

Beam Therapeutics (BEAM)<\/strong> \u2014 Wedbush raised its price target for the stock from $28.00 to $30.00 while maintaining an Outperform rating.<\/p>\n

BETA Technologies (BETA)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating, with a price target of $31.00.<\/p>\n

BETA Technologies (BETA)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $34.00 to $28.00 while maintaining a Buy rating.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $87.00 to $86.00 while maintaining an Overweight rating.<\/p>\n

BioNTech (BNTX)<\/strong> \u2014 Bank of America reiterated its Buy rating.<\/p>\n

BioNTech (BNTX)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $114.00 to $106.00 while maintaining an Overweight rating.<\/p>\n

BioNTech (BNTX)<\/strong> \u2014 UBS Group lowered its price target for the stock from $135.00 to $125.00 while maintaining a Buy rating.<\/p>\n

BioNTech (BNTX)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $140.00 to $125.00 while maintaining an Overweight rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Bank of America raised its price target for the stock from $115.00 to $117.00 while maintaining a Buy rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Citizens Jmp reiterated its Market Perform rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $80.00 to $82.00 while maintaining an Equal Weight rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, with a price target of $100.00.<\/p>\n

Block (XYZ)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $95.00 to $103.00 while maintaining an Outperform rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Scotiabank raised its price target for the stock from $82.00 to $89.00 while maintaining a Sector Perform rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 Susquehanna raised its price target for the stock from $100.00 to $110.00 while maintaining a Positive rating.<\/p>\n

Block (XYZ)<\/strong> \u2014 TD Cowen raised its price target for the stock from $105.00 to $109.00 while maintaining a Buy rating.<\/p>\n

Blue Owl Capital (OWL)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating, with a price target of $15.00.<\/p>\n

Boise Cascade (BCC)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $97.00 to $86.00 while maintaining a Buy rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 B. Riley Financial lowered its price target for the stock from $274.00 to $265.00 while maintaining a Buy rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Bank of America lowered its price target for the stock from $232.00 to $219.00 while maintaining a Buy rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Barclays lowered its price target for the stock from $210.00 to $170.00 while maintaining an Overweight rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating, with a price target of $245.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 BTIG Research reiterated its Buy rating, with a price target of $250.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $170.00 to $150.00 while maintaining a Neutral rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Citigroup reiterated its Outperform rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Citigroup lowered its price target for the stock from $236.00 to $220.00 while maintaining a Buy rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Citizens Jmp reiterated its Market Perform rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $248.00 to $205.00 while maintaining an Overweight rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Mizuho set a price target of $205.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating, and revised its price target from $230.00 to $200.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Piper Sandler reiterated its Neutral rating, and revised its price target from $215.00 to $200.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Rosenblatt Securities lowered its price target for the stock from $245.00 to $210.00 while maintaining a Buy rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $220.00 to $205.00 while maintaining an Outperform rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Susquehanna reiterated its Positive rating, and revised its price target from $240.00 to $200.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 The Goldman Sachs Group reiterated its Neutral rating, with a price target of $175.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Wedbush lowered its price target for the stock from $247.00 to $210.00 while maintaining an Outperform rating.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Wells Fargo & Company reiterated its Positive rating, and revised its price target from $190.00 to $179.00.<\/p>\n

Broadridge Financial Solutions (BR)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $191.00 to $201.00 while maintaining a Neutral rating.<\/p>\n

Broadridge Financial Solutions (BR)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $176.00 to $181.00 while maintaining an Equal Weight rating.<\/p>\n

Cabot (CBT)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $100.00 to $95.00 while maintaining a Buy rating.<\/p>\n

Cabot (CBT)<\/strong> \u2014 UBS Group lowered its price target for the stock from $86.00 to $80.00 while maintaining a Neutral rating.<\/p>\n

Calix (CALX)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $58.00 to $50.00 while maintaining an Overweight rating.<\/p>\n

Calix (CALX)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $55.00.<\/p>\n

Camping World (CWH)<\/strong> \u2014 Citigroup downgraded the stock from Buy to Neutral, adjusting its price target from $7.00 to $5.00.<\/p>\n

Camping World (CWH)<\/strong> \u2014 KeyCorp lowered its price target for the stock from $8.00 to $7.00 while maintaining an Overweight rating.<\/p>\n

Camtek (CAMT)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $170.00 to $130.00 while maintaining a Buy rating.<\/p>\n

Camtek (CAMT)<\/strong> \u2014 Stifel Nicolaus set a price target of $140.00.<\/p>\n

CarMax (KMX)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $70.00 to $65.00 while maintaining a Neutral rating.<\/p>\n

CarMax (KMX)<\/strong> \u2014 Mizuho set a price target of $50.00.<\/p>\n

Celanese (CE)<\/strong> \u2014 Barclays raised its price target for the stock from $49.00 to $57.00 while maintaining an Equal Weight rating.<\/p>\n

Celanese (CE)<\/strong> \u2014 Citigroup raised its price target for the stock from $58.00 to $65.00 while maintaining a Buy rating.<\/p>\n

Celanese (CE)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $76.00 to $77.00 while maintaining an Overweight rating.<\/p>\n

Central Bancompany (CBC)<\/strong> \u2014 Bank of America downgraded the stock from Buy to Neutral, with a price target of $36.50.<\/p>\n

CeriBell (CBLL)<\/strong> \u2014 BTIG Research reiterated its Buy rating.<\/p>\n

CeriBell (CBLL)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $26.00 to $33.00 while maintaining a Buy rating.<\/p>\n

Chemours (CC)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $20.00 to $18.00 while maintaining a Buy rating.<\/p>\n

Chemours (CC)<\/strong> \u2014 UBS Group lowered its price target for the stock from $16.00 to $15.00 while maintaining a Neutral rating.<\/p>\n

Cinemark (CNK)<\/strong> \u2014 Wedbush raised its price target for the stock from $45.00 to $46.00 while maintaining an Outperform rating.<\/p>\n

Cinemark (CNK)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $34.00 to $42.00 while maintaining an Equal Weight rating.<\/p>\n

Cipher Mining (CIFR)<\/strong> \u2014 Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform, with a price target of $9.50.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Citigroup reiterated its Market Perform rating.<\/p>\n

Cleanspark (CLSK)<\/strong> \u2014 Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform, with a price target of $9.50.<\/p>\n

CLEAR Secure (YOU)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $70.00 to $90.00 while maintaining a Buy rating.<\/p>\n

CLEAR Secure (YOU)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating, with a price target of $80.00.<\/p>\n

Clorox (CLX)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $87.00 to $94.00 while maintaining an Equal Weight rating.<\/p>\n

Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating, with a price target of $110.00.<\/p>\n

Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 UBS Group raised its price target for the stock from $107.00 to $115.00 while maintaining a Neutral rating.<\/p>\n

Coca-Cola Europacific Partners (CCEP)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $115.00 to $120.00 while maintaining an Overweight rating.<\/p>\n

Columbus McKinnon (CMCO)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $29.00 to $30.00 while maintaining an Overweight rating.<\/p>\n

Community Health Systems (CYH)<\/strong> \u2014 Barclays lowered its price target for the stock from $2.50 to $2.00 while maintaining an Underweight rating.<\/p>\n

Community West Bancshares (CWBC)<\/strong> \u2014 Keefe, Bruyette & Woods reiterated its Market Perform rating.<\/p>\n

Compass Pathways (CMPS)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating.<\/p>\n

Compass Pathways (CMPS)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $13.00 to $10.00 while maintaining an Equal Weight rating.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Bank of America upgraded the stock from Underperform to Neutral, with a price target of $160.00.<\/p>\n

Contineum Therapeutics (CTNM)<\/strong> \u2014 Stifel Nicolaus set a price target of $23.00.<\/p>\n

COPT Defense Properties (CDP)<\/strong> \u2014 Citigroup lowered its price target for the stock from $40.00 to $36.00 while maintaining a Neutral rating.<\/p>\n

Corcept Therapeutics (CORT)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating, and revised its price target from $165.00 to $173.00.<\/p>\n

Core & Main (CNM)<\/strong> \u2014 Jefferies Financial Group initiated coverage with a Buy rating and a $53.00 price target.<\/p>\n

CoreWeave (CRWV)<\/strong> \u2014 Citigroup lowered its price target for the stock from $159.00 to $128.00 while maintaining a Buy rating.<\/p>\n

Coupang (CPNG)<\/strong> \u2014 Citigroup upgraded the stock from Neutral to Buy, with a price target of $19.00.<\/p>\n

Coupang (CPNG)<\/strong> \u2014 Mizuho set a price target of $21.00.<\/p>\n

Crescent Energy (CRGY)<\/strong> \u2014 Truist Financial raised its price target for the stock from $19.00 to $20.00 while maintaining a Buy rating.<\/p>\n

Crexendo (CXDO)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating.<\/p>\n

CRH (CRH)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $139.00 to $129.00 while maintaining an Overweight rating.<\/p>\n

CRISPR Therapeutics (CRSP)<\/strong> \u2014 Citigroup raised its price target for the stock from $88.00 to $90.00 while maintaining a Buy rating.<\/p>\n

CRISPR Therapeutics (CRSP)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $75.00 to $70.00 while maintaining an Equal Weight rating.<\/p>\n

Crown (CCK)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $121.00.<\/p>\n

CubeSmart (CUBE)<\/strong> \u2014 UBS Group raised its price target for the stock from $38.00 to $44.00 while maintaining a Neutral rating.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $103.00.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating, with a price target of $120.00.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 TD Cowen reiterated its Buy rating.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 UBS Group set a price target of $110.00.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $289.00 to $260.00 while maintaining a Buy rating.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Guggenheim reiterated its Buy rating.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating, with a price target of $230.00.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, with a price target of $300.00.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Stifel Nicolaus set a price target of $245.00.<\/p>\n

Denali Therapeutics (DNLI)<\/strong> \u2014 BTIG Research reiterated its Buy rating, with a price target of $39.00.<\/p>\n

Denali Therapeutics (DNLI)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $40.00 to $42.00 while maintaining an Overweight rating.<\/p>\n

Denali Therapeutics (DNLI)<\/strong> \u2014 Wedbush raised its price target for the stock from $23.00 to $24.00 while maintaining an Outperform rating.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 Truist Financial raised its price target for the stock from $224.00 to $232.00 while maintaining a Buy rating.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 UBS Group raised its price target for the stock from $256.00 to $260.00 while maintaining a Buy rating.<\/p>\n

Diamondback Energy (FANG)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $263.00 to $244.00 while maintaining an Overweight rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 Barclays lowered its price target for the stock from $161.00 to $140.00 while maintaining an Overweight rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 Canaccord Genuity Group lowered its price target for the stock from $200.00 to $180.00 while maintaining a Buy rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 Citigroup lowered its price target for the stock from $190.00 to $160.00 while maintaining a Buy rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $175.00 to $150.00 while maintaining an Overweight rating.<\/p>\n

DigitalOcean (DOCN)<\/strong> \u2014 UBS Group lowered its price target for the stock from $105.00 to $100.00 while maintaining a Neutral rating.<\/p>\n

Dine Brands Global (DIN)<\/strong> \u2014 Raymond James Financial reiterated its Market Perform rating.<\/p>\n

Driven Brands (DRVN)<\/strong> \u2014 Barclays downgraded the stock from Equal Weight to Underweight, with a price target of $11.00.<\/p>\n

Driven Brands (DRVN)<\/strong> \u2014 BTIG Research downgraded the stock from Buy to Neutral.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Barclays raised its price target for the stock from $115.00 to $133.00 while maintaining an Equal Weight rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Citigroup reiterated its Market Perform rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Citigroup raised its price target for the stock from $140.00 to $152.00 while maintaining a Neutral rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 DA Davidson set a price target of $180.00.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Evercore set a price target of $128.00.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $135.00 to $155.00 while maintaining a Neutral rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $140.00 to $145.00 while maintaining an Equal Weight rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $145.00 to $165.00 while maintaining a Buy rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Scotiabank raised its price target for the stock from $120.00 to $140.00 while maintaining a Sector Perform rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 The Goldman Sachs Group set a price target of $128.00.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 UBS Group raised its price target for the stock from $150.00 to $180.00 while maintaining a Buy rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Wedbush raised its price target for the stock from $150.00 to $155.00 while maintaining a Neutral rating.<\/p>\n

Duolingo (DUOL)<\/strong> \u2014 Wells Fargo & Company upgraded the stock from Underweight to Equal Weight, adjusting its price target from $80.00 to $120.00.<\/p>\n

DuPont de Nemours (DD)<\/strong> \u2014 Barclays raised its price target for the stock from $156.00 to $176.00 while maintaining an Overweight rating.<\/p>\n

DuPont de Nemours (DD)<\/strong> \u2014 Citigroup raised its price target for the stock from $162.00 to $176.00 while maintaining a Buy rating.<\/p>\n

DuPont de Nemours (DD)<\/strong> \u2014 UBS Group raised its price target for the stock from $172.00 to $182.00 while maintaining a Buy rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Barclays lowered its price target for the stock from $71.00 to $61.00 while maintaining an Overweight rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Citigroup lowered its price target for the stock from $75.00 to $70.00 while maintaining a Buy rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Rosenblatt Securities lowered its price target for the stock from $70.00 to $65.00 while maintaining a Buy rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $73.00 to $68.00 while maintaining an Outperform rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 UBS Group lowered its price target for the stock from $80.00 to $75.00 while maintaining a Buy rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Wedbush lowered its price target for the stock from $54.00 to $50.00 while maintaining a Neutral rating.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $75.00 to $65.00 while maintaining an Overweight rating.<\/p>\n

Eastman Chemical (EMN)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $65.00 to $70.00 while maintaining a Sector Perform rating.<\/p>\n

Eaton (ETN)<\/strong> \u2014 Mizuho set a price target of $485.00.<\/p>\n

Eaton (ETN)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $526.00 to $539.00 while maintaining an Outperform rating.<\/p>\n

Eaton (ETN)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $503.00 to $485.00 while maintaining an Overweight rating.<\/p>\n

Echostar (ECHO)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $134.00 to $132.00 while maintaining an Overweight rating.<\/p>\n

Echostar (ECHO)<\/strong> \u2014 UBS Group raised its price target for the stock from $150.00 to $160.00 while maintaining a Buy rating.<\/p>\n

Edwards Lifesciences (EW)<\/strong> \u2014 Truist Financial set a price target of $95.00 to $113.00 with a Hold to Buy rating.<\/p>\n

EMCOR Group (EME)<\/strong> \u2014 UBS Group lowered its price target for the stock from $1,065.00 to $925.00 while maintaining a Buy rating.<\/p>\n

Enpro (NPO)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $430.00 to $440.00 while maintaining an Overweight rating.<\/p>\n

EPAM Systems (EPAM)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $97.00 to $140.00 while maintaining an Equal Weight rating.<\/p>\n

Equitable (EQH)<\/strong> \u2014 Truist Financial raised its price target for the stock from $60.00 to $65.00 while maintaining a Buy rating.<\/p>\n

Estee Lauder Companies (EL)<\/strong> \u2014 Barclays raised its price target for the stock from $108.00 to $126.00 while maintaining an Overweight rating.<\/p>\n

Everest Group (EG)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target for the stock from $407.00 to $450.00 while maintaining an Outperform rating.<\/p>\n

Evertec (EVTC)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target for the stock from $38.00 to $42.00 while maintaining an Outperform rating.<\/p>\n

Expeditors International of Washington (EXPD)<\/strong> \u2014 Barclays raised its price target for the stock from $165.00 to $175.00 while maintaining an Underweight rating.<\/p>\n

Expeditors International of Washington (EXPD)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $214.00 to $220.00 while maintaining a Neutral rating.<\/p>\n

Expeditors International of Washington (EXPD)<\/strong> \u2014 Truist Financial raised its price target for the stock from $175.00 to $200.00 while maintaining a Hold rating.<\/p>\n

Expeditors International of Washington (EXPD)<\/strong> \u2014 UBS Group raised its price target for the stock from $220.00 to $245.00 while maintaining a Buy rating.<\/p>\n

Expro Group (XPRO)<\/strong> \u2014 Piper Sandler lowered its price target for the stock from $16.00 to $15.00 while maintaining an Underweight rating.<\/p>\n

Extra Space Storage (EXR)<\/strong> \u2014 UBS Group raised its price target for the stock from $152.00 to $174.00 while maintaining a Buy rating.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 Citigroup raised its price target for the stock from $155.00 to $175.00 while maintaining a Neutral rating.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 DZ Bank downgraded the stock from Hold to Sell, with a price target of $170.00.<\/p>\n

ExxonMobil (XOM)<\/strong> \u2014 TD Cowen raised its price target for the stock from $180.00 to $193.00 while maintaining a Buy rating.<\/p>\n

Fabrinet (FN)<\/strong> \u2014 Barclays lowered its price target for the stock from $739.00 to $496.00 while maintaining an Overweight rating.<\/p>\n

Ferrovial (FER)<\/strong> \u2014 Citigroup upgraded the stock from Neutral to Buy.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $38.00.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Oppenheimer downgraded the stock from Outperform to Market Perform.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating, with a price target of $35.00.<\/p>\n

Fidelity National Information Services (FIS)<\/strong> \u2014 William Blair downgraded the stock from Outperform to Market Perform.<\/p>\n

Firefly Aerospace (FLY)<\/strong> \u2014 B. Riley Financial lowered its price target for the stock from $50.00 to $40.00 while maintaining a Buy rating.<\/p>\n

First Watch Restaurant Group (FWRG)<\/strong> \u2014 Stephens reiterated its Overweight rating, with a price target of $18.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Argus upgraded the stock from Hold to Buy, with a price target of $72.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 B. Riley Financial reiterated its Neutral rating, and revised its price target from $51.00 to $60.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Barclays raised its price target for the stock from $50.00 to $59.00 while maintaining an Equal Weight rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Citigroup raised its price target for the stock from $53.00 to $62.00 while maintaining a Neutral rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $60.00 to $65.00 while maintaining a Neutral rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target for the stock from $60.00 to $70.00 while maintaining an Outperform rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $59.00 to $61.00 while maintaining an Equal Weight rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $65.00 to $70.00 while maintaining an Outperform rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 TD Cowen raised its price target for the stock from $49.00 to $59.00 while maintaining a Hold rating.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 UBS Group raised its price target for the stock from $60.00 to $68.00 while maintaining a Neutral rating.<\/p>\n

Flagstar Bank, National Association (FLG)<\/strong> \u2014 Morgan Stanley downgraded the stock from Overweight to Underweight, adjusting its price target from $15.00 to $12.00.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 BTIG Research raised its price target for the stock from $95.00 to $96.00 while maintaining a Buy rating.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $160.00.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Stifel Nicolaus set a price target of $124.00.<\/p>\n

Flux Power Holdings (FLUX)<\/strong> \u2014 Lake Street downgraded the stock from Buy to Hold, with a price target of $1.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 B. Riley Financial reiterated its Buy rating, and revised its price target from $24.00 to $25.00.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 BTIG Research raised its price target for the stock from $20.00 to $22.00 while maintaining a Buy rating.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $20.00 to $23.00 while maintaining a Neutral rating.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $24.00 to $26.00 while maintaining an Overweight rating.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating, with a price target of $24.00.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 UBS Group raised its price target for the stock from $19.00 to $21.50 while maintaining a Neutral rating.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Daiwa Securities Group upgraded the stock from Neutral to Outperform, with a price target of $150.00.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Barclays lowered its price target for the stock from $47.00 to $40.00 while maintaining an Equal Weight rating.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 DA Davidson set a price target of $58.00.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $49.00 to $48.00 while maintaining an Outperform rating.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $70.00 to $60.00 while maintaining a Buy rating.<\/p>\n

Fortune Brands Innovations (FBIN)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $48.00 to $51.00 while maintaining an Overweight rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $15.00 to $17.00 while maintaining a Buy rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $15.00 to $20.00 while maintaining an Overweight rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, with a price target of $15.00.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Oppenheimer reiterated its Market Perform rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Piper Sandler raised its price target for the stock from $12.00 to $15.00 while maintaining a Neutral rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 UBS Group raised its price target for the stock from $14.00 to $17.00 while maintaining a Buy rating.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Wolfe Research downgraded the stock from Outperform to Peer Perform.<\/p>\n

Gaming and Leisure Properties (GLPI)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $48.00 to $42.00 while maintaining a Neutral rating.<\/p>\n

Gaming and Leisure Properties (GLPI)<\/strong> \u2014 Citigroup lowered its price target for the stock from $59.00 to $49.00 while maintaining a Buy rating.<\/p>\n

Gartner (IT)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating, with a price target of $231.00.<\/p>\n

Gartner (IT)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $182.00 to $192.00 while maintaining an Equal Weight rating.<\/p>\n

Gartner (IT)<\/strong> \u2014 The Goldman Sachs Group raised its price target for the stock from $181.00 to $207.00 while maintaining a Neutral rating.<\/p>\n

Gartner (IT)<\/strong> \u2014 Truist Financial downgraded the stock from Buy to Hold, adjusting its price target from $235.00 to $210.00.<\/p>\n

Gartner (IT)<\/strong> \u2014 UBS Group raised its price target for the stock from $208.00 to $220.00 while maintaining a Neutral rating.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 Jefferies Financial Group set a price target of $196.00.<\/p>\n

Gladstone Commercial (GOOD)<\/strong> \u2014 B. Riley Financial reiterated its Neutral rating, and revised its price target from $12.50 to $11.50.<\/p>\n

GlobalFoundries (GFS)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating, with a price target of $50.00.<\/p>\n

GlobalFoundries (GFS)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $80.00 to $55.00 while maintaining a Buy rating.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $11.50 to $12.00 while maintaining an Overweight rating.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Raymond James Financial reiterated coverage.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $9.00 to $12.00 while maintaining a Sector Perform rating.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Truist Financial reiterated its Hold rating, and revised its price target from $9.00 to $10.00.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Truist Financial set a price target of $9.00.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 UBS Group raised its price target for the stock from $9.50 to $11.50 while maintaining a Neutral rating.<\/p>\n

Group 1 Automotive (GPI)<\/strong> \u2014 Jefferies Financial Group set a price target of $250.00.<\/p>\n

Group 1 Automotive (GPI)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Neutral to Underweight, adjusting its price target from $255.00 to $250.00.<\/p>\n

Grupo Televisa (TV)<\/strong> \u2014 UBS Group lowered its price target for the stock from $3.20 to $2.30 while maintaining a Neutral rating.<\/p>\n

GXO Logistics (GXO)<\/strong> \u2014 Susquehanna set a price target of $72.00.<\/p>\n

GXO Logistics (GXO)<\/strong> \u2014 TD Cowen reiterated its Buy rating.<\/p>\n

Hagerty (HGTY)<\/strong> \u2014 Citizens Jmp raised its price target for the stock from $15.00 to $19.00 while maintaining a Market Outperform rating.<\/p>\n

Hagerty (HGTY)<\/strong> \u2014 Truist Financial raised its price target for the stock from $13.00 to $16.00 while maintaining a Hold rating.<\/p>\n

Hagerty (HGTY)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $14.00 to $17.00 while maintaining an Equal Weight rating.<\/p>\n

Haleon (HLN)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold.<\/p>\n

Hamilton Insurance Group (HG)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target for the stock from $40.00 to $42.00 while maintaining an Outperform rating.<\/p>\n

Hamilton Lane (HLNE)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $150.00 to $144.00 while maintaining an Overweight rating.<\/p>\n

Hamilton Lane (HLNE)<\/strong> \u2014 Keefe, Bruyette & Woods raised its price target for the stock from $116.00 to $120.00 while maintaining an Outperform rating.<\/p>\n

Hamilton Lane (HLNE)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $103.00 to $114.00 while maintaining an Overweight rating.<\/p>\n

Healthpeak Properties (DOC)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $23.00 to $21.00 while maintaining a Neutral rating.<\/p>\n

HealthStream (HSTM)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $29.00 to $32.00 while maintaining a Hold rating.<\/p>\n

Hecla Mining (HL)<\/strong> \u2014 Scotiabank lowered its price target for the stock from $21.00 to $20.00 while maintaining a Sector Perform rating.<\/p>\n

Henry Schein (HSIC)<\/strong> \u2014 UBS Group raised its price target for the stock from $94.00 to $95.00 while maintaining a Neutral rating.<\/p>\n

Hess Midstream Partners (HESM)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $40.00 to $34.00 while maintaining an Equal Weight rating.<\/p>\n

Hillman Solutions (HLMN)<\/strong> \u2014 Canaccord Genuity Group lowered its price target for the stock from $13.00 to $12.00 while maintaining a Buy rating.<\/p>\n

Huntsman (HUN)<\/strong> \u2014 Barclays raised its price target for the stock from $10.00 to $11.00 while maintaining an Equal Weight rating.<\/p>\n

Huntsman (HUN)<\/strong> \u2014 Citigroup raised its price target for the stock from $9.00 to $10.00 while maintaining a Neutral rating.<\/p>\n

Huntsman (HUN)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $9.00 to $10.00 while maintaining a Sector Perform rating.<\/p>\n

Huntsman (HUN)<\/strong> \u2014 UBS Group raised its price target for the stock from $9.00 to $10.00 while maintaining a Neutral rating.<\/p>\n

Huron Consulting Group (HURN)<\/strong> \u2014 Wedbush raised its price target for the stock from $160.00 to $220.00 while maintaining an Outperform rating.<\/p>\n

Ibotta (IBTA)<\/strong> \u2014 Citigroup raised its price target for the stock from $34.00 to $60.00 while maintaining a Neutral rating.<\/p>\n

IDEAYA Biosciences (IDYA)<\/strong> \u2014 Guggenheim lowered its price target for the stock from $57.00 to $52.00 while maintaining a Buy rating.<\/p>\n

IDEAYA Biosciences (IDYA)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $48.00 to $45.00 while maintaining an Outperform rating.<\/p>\n

IDEAYA Biosciences (IDYA)<\/strong> \u2014 Wedbush raised its price target for the stock from $60.00 to $63.00 while maintaining an Outperform rating.<\/p>\n

Innovative Industrial Properties (IIPR)<\/strong> \u2014 Piper Sandler raised its price target for the stock from $44.00 to $46.00 while maintaining an Underweight rating.<\/p>\n

Insmed (INSM)<\/strong> \u2014 HC Wainwright resumed coverage with a Buy rating and a $220.00 price target.<\/p>\n

Insulet (PODD)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $200.00.<\/p>\n

Insulet (PODD)<\/strong> \u2014 TD Cowen reiterated its Hold rating.<\/p>\n

Intuitive Machines (LUNR)<\/strong> \u2014 B. Riley Financial lowered its price target for the stock from $43.00 to $34.00 while maintaining a Buy rating.<\/p>\n

IPG Photonics (IPGP)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $43.00 to $50.00 while maintaining a Neutral to Overweight rating.<\/p>\n

Isabella Bank Corporation (ISBA)<\/strong> \u2014 Piper Sandler upgraded the stock from Neutral to Overweight, with a price target of $50.<\/p>\n

Jackson Financial (JXN)<\/strong> \u2014 Barclays raised its price target for the stock to $42.00 while maintaining a Buy rating.<\/p>\n

Janus Living (JAN)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $34.00 to $33.00 while maintaining an Overweight rating.<\/p>\n

JFrog (FROG)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating, with a price target of $115.00.<\/p>\n

Kardigan (KARD)<\/strong> \u2014 H.C. Wainwright initiated coverage with a Buy rating and a $42 price target.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 Citigroup raised its price target for the stock from $37.00 to $40.00 while maintaining a Buy rating.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $39.00 to $41.00 while maintaining an Overweight rating.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $38.00 to $40.00 while maintaining an Overweight rating.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 TD Cowen raised its price target for the stock from $33.00 to $35.00 while maintaining a Hold rating.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 UBS Group raised its price target for the stock from $39.00 to $42.00 while maintaining a Buy rating.<\/p>\n

Keurig Dr Pepper (KDP)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $37.00 to $40.00 while maintaining an Overweight rating.<\/p>\n

Kraft Heinz (KHC)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating, with a price target of $24.00.<\/p>\n

Largo (LGO)<\/strong> \u2014 HC Wainwright lowered its price target for the stock from $33.00 to $61.00 while maintaining a Buy rating.<\/p>\n

Leidos (LDOS)<\/strong> \u2014 Guggenheim reiterated its Buy rating, with a price target of $160.00.<\/p>\n

LendingTree (TREE)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $48.00 to $40.00 while maintaining an Overweight rating.<\/p>\n

LendingTree (TREE)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $70.00 to $65.00 while maintaining a Buy rating.<\/p>\n

Lindblad Expeditions (LIND)<\/strong> \u2014 Stifel Nicolaus set a price target of $43.00.<\/p>\n

LivaNova (LIVN)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

LivaNova (LIVN)<\/strong> \u2014 Mizuho set a price target of $115.00.<\/p>\n

LivaNova (LIVN)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $93.00 to $112.00 while maintaining a Buy rating.<\/p>\n

LivaNova (LIVN)<\/strong> \u2014 Raymond James Financial set a price target of $120.00.<\/p>\n

Lockheed Martin (LMT)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating and a $735.00 price target.<\/p>\n

Louisiana-Pacific (LPX)<\/strong> \u2014 Barclays lowered its price target for the stock from $88.00 to $86.00 while maintaining an Overweight rating.<\/p>\n

Louisiana-Pacific (LPX)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $90.00.<\/p>\n

Louisiana-Pacific (LPX)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $84.00 to $85.00 while maintaining an Outperform rating.<\/p>\n

Louisiana-Pacific (LPX)<\/strong> \u2014 Truist Financial reiterated its Buy rating, and revised its price target from $89.00 to $84.00.<\/p>\n

Madrigal Pharmaceuticals (MDGL)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $612.00 to $633.00 while maintaining a Buy rating.<\/p>\n

Madrigal Pharmaceuticals (MDGL)<\/strong> \u2014 Truist Financial reiterated its Buy rating, and revised its price target from $709.00 to $743.00.<\/p>\n

Marathon Petroleum (MPC)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $453.00 to $458.00 while maintaining an Overweight rating.<\/p>\n

Marathon Petroleum (MPC)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $560.00 to $564.00 while maintaining an Overweight rating.<\/p>\n

Marqeta (MQ)<\/strong> \u2014 Susquehanna reiterated its Outperform rating.<\/p>\n

Marriott International (MAR)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

Marriott International (MAR)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating, with a price target of $445.00.<\/p>\n

Marzetti (MZTI)<\/strong> \u2014 Stephens reiterated its Equal Weight rating, with a price target of $135.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $353.00.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 TD Cowen raised its price target for the stock from $270.00 to $285.00 while maintaining a Hold rating.<\/p>\n

Metallus (MTUS)<\/strong> \u2014 KeyCorp reiterated coverage.<\/p>\n

MiNK Therapeutics (INKT)<\/strong> \u2014 HC Wainwright resumed coverage with a Buy rating and a $38.00 price target.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $155.00 to $160.00 while maintaining an Overweight rating.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Citizens Jmp raised its price target for the stock from $144.00 to $167.00 while maintaining a Market Outperform rating.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 HC Wainwright raised its price target for the stock from $200.00 to $202.00 while maintaining a Buy rating.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating, with a price target of $189.00.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating, with a price target of $155.00.<\/p>\n

Modine Manufacturing (MOD)<\/strong> \u2014 KeyCorp lowered its price target for the stock from $280.00 to $225.00 while maintaining an Overweight rating.<\/p>\n

Mosaic (MOS)<\/strong> \u2014 Mizuho set a price target of $20.00.<\/p>\n

MSG Knickerbockers Corp (MSGK)<\/strong> \u2014 Wolfe Research upgraded the stock from Peer Perform to Outperform.<\/p>\n

MSG Rangers Corp (MSGR)<\/strong> \u2014 Wolfe Research initiated coverage with an Outperform rating.<\/p>\n

Mvb Financial (MVBF)<\/strong> \u2014 Keefe, Bruyette & Woods lowered its price target for the stock from $34.00 to $31.00 while maintaining an Outperform rating.<\/p>\n

Nabors Industries (NBR)<\/strong> \u2014 Citigroup lowered its price target for the stock from $110.00 to $100.00 while maintaining a Neutral rating.<\/p>\n

Navitas Semiconductor (NVTS)<\/strong> \u2014 Craig Hallum upgraded the stock from Hold to Buy, with a price target of $13.00.<\/p>\n

Navitas Semiconductor (NVTS)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $21.00 to $15.00 while maintaining a Buy rating.<\/p>\n

Navitas Semiconductor (NVTS)<\/strong> \u2014 Rosenblatt Securities upgraded the stock from Neutral to Buy, with a price target of $13.00.<\/p>\n

Nebius Group (NBIS)<\/strong> \u2014 Citigroup lowered its price target for the stock from $324.00 to $265.00 while maintaining a Buy rating.<\/p>\n

Neostellar Capital (NSLR)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $14.00 to $13.00 while maintaining a Buy rating.<\/p>\n

Netskope (NTSK)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with an Overweight rating and a $28.00 price target.<\/p>\n

Neurocrine Biosciences (NBIX)<\/strong> \u2014 Guggenheim raised its price target for the stock from $207.00 to $224.00 while maintaining a Buy rating.<\/p>\n

Neutron (LIME)<\/strong> \u2014 Citizens Jmp lowered its price target for the stock from $33.00 to $27.00 while maintaining a Market Outperform rating.<\/p>\n

Neutron (LIME)<\/strong> \u2014 Evercore reiterated its Outperform rating, with a price target of $35.00.<\/p>\n

Neutron (LIME)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $38.00 to $33.00 while maintaining an Overweight rating.<\/p>\n

Neutron (LIME)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $36.00 to $29.00 while maintaining a Buy rating.<\/p>\n

Neutron (LIME)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating, with a price target of $37.00.<\/p>\n

Neutron (LIME)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

New Mountain Finance (NMFC)<\/strong> \u2014 Bank of America reiterated coverage.<\/p>\n

New Mountain Finance (NMFC)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $7.50 to $7.00 while maintaining an Equal Weight rating.<\/p>\n

Nomad Foods (NOMD)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $15.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 Cfra upgraded the stock from Strong Sell to Hold.<\/p>\n

Nucor (NUE)<\/strong> \u2014 KeyCorp raised its price target for the stock from $286.00 to $301.00 while maintaining an Overweight rating.<\/p>\n

Nurix Therapeutics (NRIX)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $25.00 to $20.00 while maintaining an Overweight rating.<\/p>\n

Nuveen Churchill Direct Lending (NCDL)<\/strong> \u2014 Keefe, Bruyette & Woods lowered its price target for the stock from $13.50 to $13.00 while maintaining a Market Perform rating.<\/p>\n

Nuveen Churchill Direct Lending (NCDL)<\/strong> \u2014 Wells Fargo & Company reiterated its Underweight rating, with a price target of $11.00.<\/p>\n

Oculis (OCS)<\/strong> \u2014 Guggenheim lowered its price target for the stock to $40.00 while maintaining a Buy rating.<\/p>\n

ON (ONON)<\/strong> \u2014 Wells Fargo & Company initiated coverage with an Overweight rating and a $48.00 price target.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 BTIG Research reiterated its Buy rating, with a price target of $95.00.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 Scotiabank raised its price target for the stock from $86.00 to $87.00 while maintaining a Sector Outperform rating.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $85.00 to $86.00 while maintaining an Equal Weight rating.<\/p>\n

OneMain (OMF)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $65.00 to $62.00 while maintaining an Equal Weight rating.<\/p>\n

ONEOK (OKE)<\/strong> \u2014 Argus set a price target of $108.00.<\/p>\n

onsemi (ON)<\/strong> \u2014 Citigroup lowered its price target for the stock from $98.00 to $80.00 while maintaining a Neutral rating.<\/p>\n

Oportun Financial (OPRT)<\/strong> \u2014 Stephens raised its price target for the stock from $12.00 to $14.00 while maintaining an Overweight rating.<\/p>\n

Otter Tail (OTTR)<\/strong> \u2014 Siebert Williams Shank upgraded the stock from Hold to Buy, with a price target of $91.00.<\/p>\n

Ouster (OUST)<\/strong> \u2014 Cantor Fitzgerald upgraded the stock from Neutral to Overweight, with a price target of $45.00.<\/p>\n

Ouster (OUST)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Ouster (OUST)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $53.00.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 Barclays raised its price target for the stock from $75.00 to $80.00 while maintaining an Overweight rating.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Barclays raised its price target for the stock from $265.00 to $273.00 while maintaining an Overweight rating.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 KeyCorp reiterated coverage.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Raymond James Financial set a price target of $255.00.<\/p>\n

Penguin Solutions (PENG)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $100.00.<\/p>\n

PennyMac Mortgage Investment Trust (PMT)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $10.00 to $9.00 while maintaining an Equal Weight rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 Citigroup lowered its price target for the stock from $52.00 to $47.00 while maintaining a Buy rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 Citizens Jmp lowered its price target for the stock from $54.00 to $47.00 while maintaining a Market Outperform rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 KeyCorp lowered its price target for the stock from $50.00 to $44.00 while maintaining an Overweight rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 TD Cowen lowered its price target for the stock from $70.00 to $60.00 while maintaining a Buy rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 The Goldman Sachs Group lowered its price target for the stock from $63.00 to $56.00 while maintaining a Buy rating.<\/p>\n

People Incorporated Common Stock (PPLI)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $62.00 to $59.00 while maintaining a Buy rating.<\/p>\n

Performance Food Group (PFGC)<\/strong> \u2014 TD Cowen raised its price target for the stock from $110.00 to $125.00 while maintaining a Buy rating.<\/p>\n

Pershing Square (PS)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $44.00 to $45.00 while maintaining a Sector Perform rating.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Argus set a price target of $40.00.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Citigroup raised its price target for the stock from $27.00 to $30.00 while maintaining a Neutral rating.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $25.00 to $28.00 while maintaining a Sector Perform rating.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Scotiabank raised its price target for the stock from $33.00 to $35.00 while maintaining a Sector Outperform rating.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 UBS Group raised its price target for the stock from $27.00 to $30.00 while maintaining a Neutral rating.<\/p>\n

Phillips 66 (PSX)<\/strong> \u2014 Citigroup raised its price target for the stock from $297.00 to $302.00 while maintaining a Neutral rating.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 B. Riley Financial downgraded the stock from Buy to Neutral, adjusting its price target from $44.00 to $25.00.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 Barrington Research downgraded the stock from Outperform to Market Perform.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 Morgan Stanley downgraded the stock from Overweight to Equal Weight, with a price target of $28.00.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $38.00 to $23.00 while maintaining a Hold rating.<\/p>\n

PJT Partners (PJT)<\/strong> \u2014 Keefe, Bruyette & Woods lowered its price target for the stock from $159.00 to $155.00 while maintaining a Market Perform rating.<\/p>\n

Primo Brands (PRMB)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating.<\/p>\n

Procore Technologies (PCOR)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $69.00 to $74.00 while maintaining an Overweight rating.<\/p>\n

Procore Technologies (PCOR)<\/strong> \u2014 Mizuho set a price target of $68.00.<\/p>\n

ProPetro (PUMP)<\/strong> \u2014 Citigroup lowered its price target for the stock from $14.50 to $12.00 while maintaining a Buy rating.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Bank of America reiterated its Neutral rating.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Barclays raised its price target for the stock from $94.00 to $98.00 while maintaining an Underweight rating.<\/p>\n

Public Storage (PSA)<\/strong> \u2014 UBS Group raised its price target for the stock from $294.00 to $334.00 while maintaining a Neutral rating.<\/p>\n

Ramaco Resources (METC)<\/strong> \u2014 B. Riley Financial lowered its price target for the stock from $24.00 to $17.00 while maintaining a Buy rating.<\/p>\n

Ramaco Resources (METC)<\/strong> \u2014 The Goldman Sachs Group lowered its price target for the stock from $8.00 to $7.00 while maintaining a Neutral rating.<\/p>\n

Rapport Therapeutics (RAPP)<\/strong> \u2014 Raymond James Financial set a price target of $73.00.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Citizens Jmp lowered its price target for the stock from $71.00 to $70.00 while maintaining a Market Outperform rating.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $71.00 to $64.00 while maintaining an Overweight rating.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Mizuho set a price target of $62.00.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Susquehanna reiterated its Positive rating, with a price target of $64.00.<\/p>\n

Redwood Trust (RWT)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $6.00 to $3.50 while maintaining an Equal Weight rating.<\/p>\n

Regal Rexnord (RRX)<\/strong> \u2014 Citigroup raised its price target for the stock from $200.00 to $210.00 while maintaining a Buy rating.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 Morgan Stanley set a price target of $25.00.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 Piper Sandler lowered its price target for the stock from $30.00 to $26.00 while maintaining an Overweight rating.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 Stifel Nicolaus set a price target of $31.00.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 TD Cowen lowered its price target for the stock from $31.00 to $25.00 while maintaining a Buy rating.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 UBS Group lowered its price target for the stock from $27.00 to $26.00 while maintaining a Neutral rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 Bank of America reiterated its Neutral rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 Barclays raised its price target for the stock from $160.00 to $175.00 while maintaining an Equal Weight rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 Cfra upgraded the stock from Hold to Buy.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $155.00 to $160.00 while maintaining a Neutral rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $135.00 to $172.00 while maintaining a Sector Perform rating.<\/p>\n

Revvity (RVTY)<\/strong> \u2014 TD Cowen raised its price target for the stock from $175.00 to $185.00 while maintaining a Buy rating.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 Citizens Jmp raised its price target for the stock from $160.00 to $166.00 while maintaining a Market Outperform rating.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 Oppenheimer reiterated its Market Perform rating.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating.<\/p>\n

RXO (RXO)<\/strong> \u2014 UBS Group raised its price target for the stock from $23.00 to $30.25 while maintaining a Neutral rating.<\/p>\n

RxSight (RXST)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $11.00 to $7.00 while maintaining a Buy rating.<\/p>\n

RxSight (RXST)<\/strong> \u2014 Piper Sandler lowered its price target for the stock from $10.00 to $8.00 while maintaining a Neutral rating.<\/p>\n

RxSight (RXST)<\/strong> \u2014 Wells Fargo & Company lowered its price target for the stock from $9.00 to $6.00 while maintaining an Equal Weight rating.<\/p>\n

Safehold (SAFE)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $13.00 to $12.00 while maintaining a Sector Perform rating.<\/p>\n

SBA Communications (SBAC)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $238.00 to $235.00 while maintaining a Buy rating.<\/p>\n

Sensei Biotherapeutics (FTH)<\/strong> \u2014 Guggenheim lowered its price target for the stock from $70.00 to $69.00 while maintaining a Buy rating.<\/p>\n

Septerna (SEPN)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $50.00 to $61.00 while maintaining an Overweight rating.<\/p>\n

SharkNinja (SN)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating, with a price target of $300.00.<\/p>\n

SharkNinja (SN)<\/strong> \u2014 William Blair reiterated its Outperform rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $158.00 to $150.00 while maintaining a Neutral rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 National Bank Financial raised its price target for the stock from $180.00 to $185.00 while maintaining an Outperform rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Rosenblatt Securities lowered its price target for the stock from $186.00 to $180.00 while maintaining a Buy rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating, with a price target of $200.00.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating, with a price target of $165.00.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 UBS Group raised its price target for the stock from $145.00 to $160.00 while maintaining a Neutral rating.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Wedbush reiterated its Outperform rating, with a price target of $176.00.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Wells Fargo & Company reiterated its Overweight rating, and revised its price target from $208.00 to $205.00.<\/p>\n

Silver Standard Resources (SSRM)<\/strong> \u2014 UBS Group lowered its price target for the stock from $39.00 to $37.00 while maintaining a Buy rating.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Bank of America lowered its price target for the stock from $78.00 to $72.00 while maintaining an Underperform rating.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Citigroup lowered its price target for the stock from $90.00 to $79.00 while maintaining a Neutral rating.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Jefferies Financial Group downgraded the stock to Buy.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Mizuho set a price target of $58.00.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Morgan Stanley set a price target of $93.00.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $95.00 to $80.00 while maintaining a Sector Perform rating.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 Susquehanna lowered its price target for the stock from $90.00 to $75.00 while maintaining a Neutral rating.<\/p>\n

Skyworks Solutions (SWKS)<\/strong> \u2014 The Goldman Sachs Group resumed coverage with a Sell rating and a $78.00 price target.<\/p>\n

Sonic Automotive (SAH)<\/strong> \u2014 Barclays lowered its price target for the stock from $75.00 to $73.00 while maintaining an Equal Weight rating.<\/p>\n

Sonic Automotive (SAH)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $63.00 to $58.00 while maintaining an Underweight rating.<\/p>\n

Sotera Health (SHC)<\/strong> \u2014 Barclays lowered its price target for the stock from $22.00 to $20.00 while maintaining an Overweight rating.<\/p>\n

Sotera Health (SHC)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $17.00 to $15.00 while maintaining an Underweight rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 Citizens Jmp lowered its price target for the stock from $20.00 to $19.00 while maintaining a Market Outperform rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 Guggenheim lowered its price target for the stock from $26.00 to $23.00 while maintaining a Buy rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $13.00 to $12.00 while maintaining a Neutral rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $17.00 to $20.00 while maintaining a Buy rating.<\/p>\n

Sportradar Group (SRAD)<\/strong> \u2014 Truist Financial raised its price target for the stock from $16.00 to $17.00 while maintaining a Buy rating.<\/p>\n

Sprout Social (SPT)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $10.00 to $13.50 while maintaining a Hold rating.<\/p>\n

Sprout Social (SPT)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $8.00 to $13.00 while maintaining a Neutral rating.<\/p>\n

Sprout Social (SPT)<\/strong> \u2014 KeyCorp raised its price target for the stock from $7.00 to $10.00 while maintaining an Underweight rating.<\/p>\n

Sprout Social (SPT)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, with a price target of $14.00.<\/p>\n

Spyre Therapeutics (SYRE)<\/strong> \u2014 Guggenheim raised its price target for the stock from $130.00 to $135.00 while maintaining a Buy rating.<\/p>\n

Spyre Therapeutics (SYRE)<\/strong> \u2014 Wedbush lowered its price target for the stock from $123.00 to $120.00 while maintaining an Outperform rating.<\/p>\n

Starwood Property Trust (STWD)<\/strong> \u2014 Keefe, Bruyette & Woods lowered its price target for the stock from $16.00 to $15.00 while maintaining an Outperform rating.<\/p>\n

Stevanato Group (STVN)<\/strong> \u2014 Citigroup lowered its price target for the stock from $26.00 to $20.00 while maintaining a Buy rating.<\/p>\n

Stevanato Group (STVN)<\/strong> \u2014 UBS Group lowered its price target for the stock from $23.00 to $16.00 while maintaining a Neutral rating.<\/p>\n

Stevanato Group (STVN)<\/strong> \u2014 William Blair downgraded the stock from Outperform to Market Perform.<\/p>\n

Sunoco (SUN)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $82.00 to $85.00 while maintaining an Overweight rating.<\/p>\n

Super Group (SGHC) (SGHC)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $19.00 to $16.00 while maintaining a Buy rating.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Bank of America raised its price target for the stock from $38.00 to $39.00 while maintaining an Underperform rating.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Oppenheimer upgraded the stock to Outperform.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating, with a price target of $65.00.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating, with a price target of $57.00.<\/p>\n

Supernus Pharmaceuticals (SUPN)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $67.00 to $87.00 while maintaining an Overweight rating.<\/p>\n

Supernus Pharmaceuticals (SUPN)<\/strong> \u2014 Piper Sandler resumed coverage with an Overweight rating and a $47.00 price target.<\/p>\n

Sysco (SYY)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $95.00 to $92.00.<\/p>\n

Sysco (SYY)<\/strong> \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $313.00 to $262.00 while maintaining a Buy rating.<\/p>\n

Tarsus Pharmaceuticals (TARS)<\/strong> \u2014 HC Wainwright raised its price target for the stock from $88.00 to $106.00 while maintaining a Buy rating.<\/p>\n

Teladoc Health (TDOC)<\/strong> \u2014 Barclays raised its price target for the stock from $7.00 to $9.00 while maintaining an Equal Weight rating.<\/p>\n

Telesat (TSAT)<\/strong> \u2014 Desjardins initiated coverage with a Buy rating.<\/p>\n

Tenet Healthcare (THC)<\/strong> \u2014 Barclays raised its price target for the stock from $271.00 to $297.00 while maintaining an Overweight rating.<\/p>\n

Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 TD Cowen raised its price target for the stock from $55.00 to $57.00 while maintaining a Buy rating.<\/p>\n

Thomson Reuters (TRI)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $129.50 to $130.50 while maintaining a Buy rating.<\/p>\n

Thomson Reuters (TRI)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $110.00 to $115.00 while maintaining a Neutral rating.<\/p>\n

Toast (TOST)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $45.00 to $42.00 while maintaining an Overweight rating.<\/p>\n

Toast (TOST)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating, and revised its price target from $100.00 to $110.00.<\/p>\n

Toast (TOST)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating, with a price target of $39.00.<\/p>\n

Transcat (TRNS)<\/strong> \u2014 Oppenheimer upgraded the stock from Market Perform to Outperform, with a price target of $115.00.<\/p>\n

Travere Therapeutics (TVTX)<\/strong> \u2014 Canaccord Genuity Group raised its price target for the stock from $70.00 to $72.00 while maintaining a Buy rating.<\/p>\n

Travere Therapeutics (TVTX)<\/strong> \u2014 Guggenheim lowered its price target for the stock from $89.00 to $78.00 while maintaining a Buy rating.<\/p>\n

Twilio (TWLO)<\/strong> \u2014 Tigress Financial raised its price target for the stock from $255.00 to $320.00 while maintaining a Buy rating.<\/p>\n

Uber Technologies (UBER)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $100.00 to $90.00 while maintaining a Buy rating.<\/p>\n

UL Solutions (ULS)<\/strong> \u2014 Citigroup lowered its price target for the stock from $82.80 to $81.40 while maintaining a Neutral rating.<\/p>\n

UL Solutions (ULS)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $104.00 to $105.00 while maintaining an Overweight rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 Canaccord Genuity Group lowered its price target for the stock from $39.00 to $34.00 while maintaining a Buy rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $20.00 to $22.00 while maintaining an Equal Weight rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 TD Cowen raised its price target for the stock from $18.00 to $19.00 while maintaining a Buy rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 The Goldman Sachs Group lowered its price target for the stock from $19.00 to $17.00 while maintaining a Neutral rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 Wedbush lowered its price target for the stock from $25.00 to $22.00 while maintaining a Neutral rating.<\/p>\n

Ultragenyx Pharmaceutical (RARE)<\/strong> \u2014 Wells Fargo & Company raised its price target for the stock from $18.00 to $19.00 while maintaining an Equal Weight rating.<\/p>\n

uniQure (QURE)<\/strong> \u2014 Stifel Nicolaus set a price target of $71.00.<\/p>\n

United Dominion Realty Trust (UDR)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $37.00 to $38.00 while maintaining a Sector Perform rating.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 BTIG Research raised its price target for the stock from $728.00 to $768.00 while maintaining a Buy rating.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 Raymond James Financial set a price target of $720.00.<\/p>\n

Unum Group (UNM)<\/strong> \u2014 Barclays lowered its price target for the stock from $109.00 to $101.00 while maintaining an Overweight rating.<\/p>\n

Upstart (UPST)<\/strong> \u2014 B. Riley Financial reiterated its Buy rating, and revised its price target from $54.00 to $42.00.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Bank of America reiterated its Neutral rating, with a price target of $28.00.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Citigroup lowered its price target for the stock from $61.00 to $46.00 while maintaining a Buy rating.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Mizuho set a price target of $35.00.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $35.00 to $24.00 while maintaining an Equal Weight rating.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Stephens lowered its price target for the stock from $26.00 to $24.00 while maintaining an Equal Weight rating.<\/p>\n

Upstart (UPST)<\/strong> \u2014 The Goldman Sachs Group lowered its price target for the stock from $28.00 to $24.00 while maintaining a Neutral rating.<\/p>\n

Upstart (UPST)<\/strong> \u2014 Truist Financial lowered its price target for the stock from $40.00 to $30.00 while maintaining a Buy rating.<\/p>\n

UWM (UWMC)<\/strong> \u2014 The Goldman Sachs Group reiterated its Neutral rating, with a price target of $1.50.<\/p>\n

V2X (VVX)<\/strong> \u2014 BTIG Research raised its price target for the stock from $90.00 to $95.00 while maintaining a Buy rating.<\/p>\n

Valaris (VAL)<\/strong> \u2014 Susquehanna raised its price target for the stock from $86.00 to $91.00 while maintaining a Neutral rating.<\/p>\n

Varonis Systems (VRNS)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $55.00 to $49.75 while maintaining an Overweight rating.<\/p>\n

Verra Mobility (VRRM)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $5.00 to $3.00 while maintaining an Equal Weight rating.<\/p>\n

Versant (VSNT)<\/strong> \u2014 JPMorgan Chase & Co. lowered its price target for the stock from $43.00 to $39.00 while maintaining a Neutral rating.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> \u2014 Barclays raised its price target for the stock from $617.00 to $626.00 while maintaining an Overweight rating.<\/p>\n

VICI Properties (VICI)<\/strong> \u2014 Cantor Fitzgerald lowered its price target for the stock from $32.00 to $29.00 while maintaining an Overweight rating.<\/p>\n

Viper Energy (VNOM)<\/strong> \u2014 Truist Financial raised its price target for the stock from $53.00 to $54.00 while maintaining a Buy rating.<\/p>\n

Viridian Therapeutics (VRDN)<\/strong> \u2014 Needham & Company LLC raised its price target for the stock from $34.00 to $38.00 while maintaining a Buy rating.<\/p>\n

Vistra (VST)<\/strong> \u2014 KeyCorp downgraded the stock from Overweight to Sector Weight.<\/p>\n

Vital Farms (VITL)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

Vital Farms (VITL)<\/strong> \u2014 Needham & Company LLC lowered its price target for the stock from $14.00 to $13.00 while maintaining a Buy rating.<\/p>\n

VivoPower PLC Ordinary Shares (VIVO)<\/strong> \u2014 Noble Financial reiterated its Outperform rating.<\/p>\n

Voyager Technologies (VOYG)<\/strong> \u2014 BTIG Research lowered its price target for the stock from $55.00 to $50.00 while maintaining a Buy rating.<\/p>\n

Vulcan Materials (VMC)<\/strong> \u2014 Morgan Stanley lowered its price target for the stock from $321.00 to $311.00 while maintaining an Equal Weight rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 Barclays raised its price target for the stock from $500.00 to $530.00 while maintaining an Overweight rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 Citigroup raised its price target for the stock from $470.00 to $536.00 while maintaining a Buy rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $435.00 to $470.00 while maintaining a Neutral rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 KeyCorp raised its price target for the stock from $460.00 to $500.00 while maintaining an Overweight rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $475.00 to $525.00 while maintaining an Outperform rating.<\/p>\n

Waters (WAT)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating, with a price target of $535.00.<\/p>\n

Waters (WAT)<\/strong> \u2014 Stifel Nicolaus set a price target of $470.00.<\/p>\n

Waters (WAT)<\/strong> \u2014 TD Cowen raised its price target for the stock from $515.00 to $530.00 while maintaining a Buy rating.<\/p>\n

Wayfair (W)<\/strong> \u2014 Gordon Haskett upgraded the stock from Hold to Buy, with a price target of $160.00.<\/p>\n

Wayfair (W)<\/strong> \u2014 Raymond James Financial reiterated its Strong-Buy rating, with a price target of $135.00.<\/p>\n

Wayfair (W)<\/strong> \u2014 Truist Financial set a price target of $160.00.<\/p>\n

Waystar (WAY)<\/strong> \u2014 Truist Financial raised its price target for the stock from $33.00 to $35.00 while maintaining a Buy rating.<\/p>\n

Williams Companies (WMB)<\/strong> \u2014 Stifel Nicolaus set a price target of $85.00.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Cantor Fitzgerald raised its price target for the stock from $110.00 to $114.00 while maintaining an Overweight rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Citigroup raised its price target for the stock from $110.00 to $132.00 while maintaining a Buy rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Citizens Jmp raised its price target for the stock from $120.00 to $135.00 while maintaining a Market Outperform rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 JPMorgan Chase & Co. raised its price target for the stock from $120.00 to $140.00 while maintaining an Overweight rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Rosenblatt Securities raised its price target for the stock from $120.00 to $130.00 while maintaining a Buy rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $100.00 to $117.00 while maintaining a Sector Perform rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 UBS Group raised its price target for the stock from $95.00 to $108.00 while maintaining a Neutral rating.<\/p>\n

Xometry (XMTR)<\/strong> \u2014 Wedbush raised its price target for the stock from $126.00 to $140.00 while maintaining an Outperform rating.<\/p>\n

XPLR Infrastructure (XIFR)<\/strong> \u2014 Royal Bank Of Canada lowered its price target for the stock from $14.00 to $12.00 while maintaining an Outperform rating.<\/p>\n

XPLR Infrastructure (XIFR)<\/strong> \u2014 Scotiabank lowered its price target for the stock from $12.00 to $10.00 while maintaining a Sector Perform rating.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Argus downgraded the stock from Buy to Hold.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 BTIG Research reiterated its Neutral rating.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 Citigroup raised its price target for the stock from $163.00 to $171.00 while maintaining a Neutral rating.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 KeyCorp reiterated coverage.<\/p>\n

Yum! Brands (YUM)<\/strong> \u2014 Royal Bank Of Canada raised its price target for the stock from $170.00 to $180.00 while maintaining a Sector Perform rating.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Barclays raised its price target for the stock from $416.00 to $432.00 while maintaining an Overweight rating.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 BNP Paribas Exane lowered its price target for the stock from $460.00 to $455.00 while maintaining an Outperform rating.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Cfra upgraded the stock from Hold to Buy.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Citigroup lowered its price target for the stock from $400.00 to $398.00 while maintaining a Neutral rating.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Morgan Stanley raised its price target for the stock from $360.00 to $380.00 while maintaining an Equal Weight rating.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating, with a price target of $120.00.<\/p>\n

Zimmer Biomet (ZBH)<\/strong> \u2014 Stifel Nicolaus set a price target of $125.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Wall Street analyst outlookt was mixed today, but leaned cautious, with downgrades outnumbering upgrades across several major sectors. Technology showed diverging…<\/p>\n","protected":false},"author":3,"featured_media":76841,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76836","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: Nov 4th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 4th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Wall Street analyst outlookt was mixed today, but leaned cautious, with downgrades outnumbering upgrades across several major sectors. Technology showed diverging…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-05T04:15:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-05T04:39:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Wall-Street-Analyst-Updates-Banner.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"54 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 4th, 2026\",\"datePublished\":\"2026-11-05T04:15:04+00:00\",\"dateModified\":\"2026-11-05T04:39:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\"},\"wordCount\":11187,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\",\"name\":\"American Analyst Updates: Nov 4th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-05T04:15:04+00:00\",\"dateModified\":\"2026-11-05T04:39:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 4th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 4th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 4th, 2026","og_description":"Analyst Ratings (USA) Wall Street analyst outlookt was mixed today, but leaned cautious, with downgrades outnumbering upgrades across several major sectors. Technology showed diverging…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-05T04:15:04+00:00","article_modified_time":"2026-11-05T04:39:57+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Wall-Street-Analyst-Updates-Banner.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"54 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 4th, 2026","datePublished":"2026-11-05T04:15:04+00:00","dateModified":"2026-11-05T04:39:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/"},"wordCount":11187,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/","name":"American Analyst Updates: Nov 4th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-05T04:15:04+00:00","dateModified":"2026-11-05T04:39:57+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-4th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 4th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76836"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76836\/revisions"}],"predecessor-version":[{"id":76839,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76836\/revisions\/76839"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76841"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}